On Demand: Cardiology Topics
January 10, 2026 - Oasis of the Seas
“Excellent speaker, presented complex topics in an easily understandable manner.
Great course lot learned Great speaker
”
About This Course
This course provides 12 contact hours of pharmacy CE and (1.5 CEU) of live AAFP/ AMA PRA Category 1 Credit™, ACPE and pharmacology CE/CME credit.
Recorded 2026-01-20
Term of Approval is from 01/18/2026 to 01/18/2027.
Price $200 for 12 Hours
Learning Objectives
-
Outline an evidence-based approach to primary prevention of ASCVD events with a focus on LDL-C.
A focused review of optimizing LDL-C for secondary prevention.
Discuss established and emerging therapies to reduce LDL-C.
Review the effects of PCSK9 inhibitors on coronary plaque.
Identify optimal LDL-C levels for patients with very high risk ASCVD.
-
Understand the role of triglycerides in residual risk beyond LDL-C.
Review the potential role of fish oils to reduce risk of CV events.
Novel approaches to TG lowering
Update on Lipoprotein (a)
What about HDL-C – should we even bother?
-
Review epidemiology and burden of heart failure.
Provide a pragmatic, patient-centered review of contemporary HF management.
Discuss recent clinical trials of novel therapies and outline the role of “quadruple therapy” for patients with HF reduced ejection fraction.
Review evidence-based therapies for patients with HF preserved ejection fraction.
-
Review epidemiology and burden of heart failure (with preserved EF).
Discuss the recommended approach for diagnosing HFpEF and the critical importance of phenotyping.
Review evidence-based therapies for patients with HF preserved ejection fraction with a particular focus on the obese-HFpEF profile.
-
Review the pathobiology and epidemiology of cardiovascular- kidney-metabolic syndrome.
Comprehensive review of clinical trials data for cardio-kidney- metabolic therapies (from the CV perspective).
ASCVD + DM
HF (across spectrum of EF; with or without DM)
CKD (across spectrum of CKD; with or without DM)
Obesity + ASCVDItem description
-
Review the pathophysiology and management of acute coronary syndromes
Understand the role of invasive and non-invasive testing in the management of chest pain
Develop an approach to statin associated muscle symptoms
Diagnose and manage atrial fibrillation including the role of early ablation
Review guidelines for the management of aortic stenosis and mitral regurgitation
Apply the latest hypertension guidelines to achieve optimal BP in patients across CV risk spectrum
Understand the role of pre-operative cardiac testing for patients undergoing non-cardiac surgery
Diagnose and management patients with amyloid heart disease
-
Discussion of 4 cases
-
Discussion of 5 cases
Speaker
Dr. Nihar Desai, MD, MPH
Nihar R. Desai, MD, MPH is an Associate Professor of Medicine and Vice Chief of the Section of Cardiovascular Medicine at Yale University School of Medicine, an Investigator at the Center for Outcomes Research and Evaluation, and Executive Director for Bundled Payments and Clinical Service Line Operations at the Yale New Haven Health System.
Accreditation Information - Category 1
PHARMACISTS:
University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. These programs are accredited for all pharmacists.
University Learning Systems is approved by CE Broker, Tracking #50-11357 and reports to the Florida Board of Pharmacy.
CONSULTANT PHARMACISTS: Some consultant pharmacist boards accept University Learning Systems courses for recertification either as is or with board approval. Please contact your board regarding course approval and ULS with any questions.
CANADIAN PHARMACISTS:Canadian Council on Continuing Education in Pharmacy (CCCEP)accepts courses accredited by the Accreditation Council for Pharmacy Education (ACPE).
NURSE PRACTITIONERS
American Nurses Credentialing Center (ANCC)and National Certification Corporation (NCC)accepts ACPE and AAFP credit. University Learning Systems courses fulfill the pharmacology requirements for ANCC Continuing Education Hours for certification renewal.
American Association of Nurse Practitioners (AANP) accepts AAFP/ AMA PRA Category 1™ to fulfill the pharmacology requirements for AANP Continuing Education Hours for certification renewal.
NURSES
University Learning Systems is approved by the California Board of Registered Nursing, Provider Number CEP 11409, and CE Broker Tracking #50-11357:
CE Broker is approved by these Boards of Nursing: Arkansas, Florida, District of Columbia, Georgia, Kentucky, New Mexico, North Dakota, South Carolina, West Virginia.The same hours submitted to renew NP certification may be submitted to a State Board of Nursing for re-licensure.
PHYSICIANS/ PHYSICIAN ASSISTANT
The AAFP has reviewed ON DEMAND 2026-01-23 Desai - Cardiology Topics and deemed it acceptable for up to 12.00 Enduring Materials, Self-Study AAFP Prescribed credit(s). Term of Approval is from 01/18/2026 to 01/18/2027.
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
CME programs approved by the AAFP are eligible for through the American Osteopathic Association (AOA).
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for Prescribed credit from AAFP. Physician assistants may report the number of hours stated above of Category I credit for completing this program.
University Learning Systems is approved by CE Broker, Tracking #50-11357 and reports to the Florida Board of Medicine.
CANADIAN PHYSICIANS: Members of the College of Family Physicians of Canada are eligible to receive up to 15 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians.
OTHER HEALTH PROFESSIONALS: Please contact your respective board regarding approval.